229 related articles for article (PubMed ID: 26815929)
1. Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma.
Agarwal A; Kumari N; Singh R
Int Ophthalmol; 2016 Oct; 36(5):747-50. PubMed ID: 26815929
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S
Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
[TBL] [Abstract][Full Text] [Related]
4. Clinical Results of Various Treatments for Retinal Capillary Hemangioma.
Won YK; Lee MW; Shin YI; Kim JY; Jo YJ
Korean J Ophthalmol; 2020 Apr; 34(2):133-142. PubMed ID: 32233147
[TBL] [Abstract][Full Text] [Related]
5. Atypical Exophytic Retinal Capillary Hemangioma and Diagnostic Modalities.
Shechtman DL; Gold AS; McIntosh S; Steen J; Murray TG
Optom Vis Sci; 2016 Jan; 93(1):107-12. PubMed ID: 26583797
[TBL] [Abstract][Full Text] [Related]
6. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
Mennel S; Meyer CH; Callizo J
Acta Ophthalmol; 2010 Aug; 88(5):610-3. PubMed ID: 19222401
[TBL] [Abstract][Full Text] [Related]
7. Indirect laser treatment and anti-VEGF therapy of a retinal angioma, with resolution of a large serous retinal detachment, macular exudates, and macular edema.
Rarey K; Friberg TR
Semin Ophthalmol; 2010; 25(1-2):21-6. PubMed ID: 20507193
[TBL] [Abstract][Full Text] [Related]
8. Persistent exudative retinal detachment after photodynamic therapy and intravitreal bevacizumab injection for multiple retinal capillary hemangiomas in a patient with von Hippel-Lindau disease.
Tsai FY; Lau LI; Chen SJ; Lee FL; Lee SM
J Chin Med Assoc; 2014 Jan; 77(1):52-6. PubMed ID: 24206762
[TBL] [Abstract][Full Text] [Related]
9. Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma.
Ucan Gunduz G; Gelisken O; Yalcinbayir O; Guler K
Indian J Ophthalmol; 2019 Dec; 67(12):2104-2106. PubMed ID: 31755476
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL INJECTION OF PROPRANOLOL FOR THE TREATMENT OF RETINAL CAPILLARY HEMANGIOMA IN A CASE OF VON HIPPEL-LINDAU.
Karimi S; Nikkhah H; Ahmadieh H; Safi S
Retin Cases Brief Rep; 2020; 14(4):305-309. PubMed ID: 29466252
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors.
Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S
Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580
[TBL] [Abstract][Full Text] [Related]
12. [The Use of anti-VEGF preparations and PDT in the treatment of retinal juxtapapillary hemangioma - a case report].
Matušková V; Vysloužilová D
Cesk Slov Oftalmol; 2014 Oct; 70(5):196-200. PubMed ID: 25640043
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma.
Russo V; Stella A; Barone A; Scott IU; Noci ND
Int Ophthalmol; 2012 Feb; 32(1):71-5. PubMed ID: 22271068
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
Dahr SS; Cusick M; Rodriguez-Coleman H; Srivastava SK; Thompson DJ; Linehan WM; Ferris FL; Chew EY
Retina; 2007 Feb; 27(2):150-8. PubMed ID: 17290195
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Imaging in the Diagnosis of Exophytic Juxtapapillary Retinal Capillary Hemangioblastoma.
Russell JF; Villegas VM; Schwartz SG; Weng CY; Davis JL; Flynn HW; Harbour JW
Am J Ophthalmol; 2021 May; 225():128-136. PubMed ID: 33450232
[TBL] [Abstract][Full Text] [Related]
16. Preretinal neovascularization after bevacizumab injections in a patient with von Hippel-Lindau syndrome.
Walker RA; Colleaux KM
Can J Ophthalmol; 2009 Oct; 44(5):608-9. PubMed ID: 19789606
[No Abstract] [Full Text] [Related]
17. Long-Term Therapeutic Outcomes of Photodynamic Therapy-Based or Photocoagulation-Based Treatments on Retinal Capillary Hemangioma.
Huang C; Tian Z; Lai K; Zhong X; Zhou L; Xu F; Yang H; Lu L; Jin C
Photomed Laser Surg; 2018 Jan; 36(1):10-17. PubMed ID: 29068750
[TBL] [Abstract][Full Text] [Related]
18. Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.
Parodi MB; Iacono P; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1647-51. PubMed ID: 25382074
[TBL] [Abstract][Full Text] [Related]
19. Retinal capillary hemangioma treatment by indocyanine green-mediated photothrombosis.
Costa RA; Meirelles RL; Cardillo JA; Abrantes ML; Farah ME
Am J Ophthalmol; 2003 Mar; 135(3):395-8. PubMed ID: 12614766
[TBL] [Abstract][Full Text] [Related]
20. A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.
Wang KY; Cheng CK
J Ocul Pharmacol Ther; 2011 Oct; 27(5):525-30. PubMed ID: 21951171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
